Medicare Enrolled

Dr. Ruth Kagwima, M.D.

Family Medicine · Colleyville, TX
Low-engagement
4301 BROWN TRL, Colleyville, TX 76034
8172818275
In practice since 2015 (10 years)
NPI: 1487040507 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kagwima from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kagwima? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kagwima

Dr. Ruth Kagwima is a family medicine in Colleyville, TX, with 10 years in practice.

Between the years covered by Open Payments, Dr. Kagwima received a total of $6,714 from 42 pharmaceutical and/or device companies across 374 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kagwima is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice$ $6,714 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,714
Total received (2018-2024)
Avg $959/year across 7 years
Top 9% in TX for family medicine
42
Companies
374
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,714 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,226
2023
$1,132
2022
$998
2021
$1,026
2020
$654
2019
$1,026
2018
$653

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$945
Novo Nordisk Inc
$629
AstraZeneca Pharmaceuticals LP
$624
ABBVIE INC.
$536
GlaxoSmithKline, LLC.
$493
Boehringer Ingelheim Pharmaceuticals, Inc.
$478
Janssen Pharmaceuticals, Inc
$465
Astellas Pharma US Inc
$286
Takeda Pharmaceuticals U.S.A., Inc.
$208
Biohaven Pharmaceuticals, Inc.
$171
Teva Pharmaceuticals USA, Inc.
$148
PFIZER INC.
$145
Biohaven Pharmaceutical Holding Company Ltd.
$143
Bayer Healthcare Pharmaceuticals Inc.
$136
Abbott Laboratories
$131
SANOFI-AVENTIS U.S. LLC
$127
SANOFI PASTEUR INC.
$112
AbbVie Inc.
$112
Amarin Pharma Inc.
$97
Amgen Inc.
$81
Merck Sharp & Dohme Corporation
$77
Genentech USA, Inc.
$51
Eisai Inc.
$43
MannKind Corporation
$43
Exact Sciences Corporation
$38
Intuitive Surgical, Inc.
$37
Dexcom, Inc.
$34
AbbVie, Inc.
$34
Otsuka America Pharmaceutical, Inc.
$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$32
Antares Pharma, Inc.
$27
EISAI INC.
$25
Horizon Therapeutics plc
$20
TherapeuticsMD, Inc.
$19
Lundbeck LLC
$19
Paratek Pharmaceuticals, Inc.
$18
Allergan, Inc.
$18
Cranial Technologies, Inc
$17
Seqirus USA Inc
$17
VBI Vaccines (Delaware) Inc.
$16
Kowa Pharmaceuticals America, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$13
Top 3 companies account for 32.7% of total payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AJOVY · ANORO · AREXVY · Aduhelm · Aimovig · Assurity Pacemaker · BASAGLAR · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · Confirm Rx · Da Vinci Surgical System · Dexcom G6 Transmitter · Doc Band · ELIQUIS · EMGALITY · Edarbi · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · Humira · IMVEXXY · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Livalo · MOUNJARO · MYRBETRIQ · NO PRODUCT DISCUSSED · NURTEC ODT · NUZYRA · Otezla · Ozempic · PreHevbrio · QULIPTA · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPIRIVA · SYMBICORT · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TZIELD · Tresiba · Trintellix · UBRELVY · VAXELIS · VESICARE · VIMOVO · VRAYLAR · VYVANSE · Vascepa · Veozah · Vyvanse · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for family medicine in TX.

Looking for a family medicine in Colleyville?
Compare family medicines in the Colleyville area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
1,778
Per 100K population
83.2
County median income
$81,905
Nearest hospital
SAINT CAMILLUS MEDICAL CENTER
2.9 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kagwima is a family medicine, and high industry engagement (low-engagement, top 9%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Kagwima receive payments from pharmaceutical companies?
Yes. Dr. Kagwima received a total of $6,714 from 42 companies across 374 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Kagwima) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Colleyville
Browse family medicines in Colleyville ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →